EBITDA: Income before interest, taxes, depreciation and amortization.
BioAtla, Inc. (BCAB) had EBITDA of $-11.24M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-9.78M |
|
-- |
|
-- |
|
$11.26M |
|
$-11.26M |
|
$-0.53M |
|
$-9.78M |
|
$-9.78M |
|
$-9.78M |
|
$-9.78M |
|
$-9.78M |
|
$-9.78M |
|
$-9.26M |
|
|
EBITDA |
$-11.24M |
1.18M |
|
1.18M |
|
$-8.00 |
|
$-8.00 |
|
| Balance Sheet Financials | |
$8.01M |
|
$0.12M |
|
$5.82M |
|
$13.83M |
|
$21.92M |
|
-- |
|
$28.09M |
|
$50.02M |
|
$-36.19M |
|
$-36.19M |
|
$-36.19M |
|
1.27M |
|
| Cash Flow Statement Financials | |
$-48.20M |
|
-- |
|
$6.28M |
|
$49.05M |
|
$7.12M |
|
$-41.93M |
|
$5.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-48.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
27.04% |
|
27.04% |
|
-70.75% |
|
27.04% |
|
$-28.51 |
|
$-40.97 |
|
$-40.97 |
|